Bliss GVS Pharma Limited (NSE:BLISSGVS)

India · Delayed Price · Currency is INR

236.50

+2.32 (0.99%)

Apr 6, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical and Healthcare	8.10B	7.70B	7.52B	7.47B	5.77B
Pharmaceutical and Healthcare Growth	5.13%	2.48%	0.55%	29.50%	-16.26%
Total	8.10B	7.70B	7.52B	7.47B	5.77B
Total Growth	5.13%	2.48%	0.55%	29.50%	-16.26%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	530.18M	444.42M	391.62M	562.32M	865.32M
India Growth	19.30%	13.48%	-30.36%	-35.02%	49.78%
Outside India	7.49B	7.21B	7.08B	6.82B	4.82B
Outside India Growth	3.79%	1.86%	3.90%	41.39%	-22.75%
Total	8.02B	7.66B	7.47B	7.38B	5.69B
Total Growth	4.69%	2.47%	1.29%	29.76%	-16.60%

Source: S&P Global Market Intelligence.